Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study. - Specchio, N.; Marsh, E.; Devinsky, O.; Aledo-Serrano, Á.; Battaglia, D. I.; Rajaraman, R.; Keough, K.; Honda, R.; Guerrini, R.; Melikishvili, G.; Amin, S.; Jaksha, A.; et al. (Neuropediatrics, 2026)